BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20051927)

  • 1. F-18 FDG-PET in children: do we have enough counts?
    Dobbeleir A; Ham H; Goethals I; Keppens J; D'Asseler Y; Van de Wiele C
    Nucl Med Commun; 2010 Mar; 31(3):190-4. PubMed ID: 20051927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of 18F-FDG 3D mode PET image quality versus acquisition time.
    Brown C; Dempsey MF; Gillen G; Elliott AT
    Nucl Med Commun; 2010 Mar; 31(3):254-9. PubMed ID: 20032801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reduction of radiation exposure in PET examinations by data acquisition in the 3D mode].
    Brix G; Adam LE; Zaers J; Trojan H; Bellemann ME; Nosske D; Doll J
    Nuklearmedizin; 1999 Apr; 38(3):75-9. PubMed ID: 10320992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of a breath-holding acquisition method in PET/CT for pulmonary lesions.
    Yamaguchi T; Ueda O; Hara H; Sakai H; Kida T; Suzuki K; Adachi S; Ishii K
    Ann Nucl Med; 2009 Jan; 23(1):65-71. PubMed ID: 19205840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
    Strobel K; Rüdy M; Treyer V; Veit-Haibach P; Burger C; Hany TF
    Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system.
    Okubo M; Nishimura Y; Nakamatsu K; Okumura M; Shibata T; Kanamori S; Hanaoka K; Hosono M
    Ann Nucl Med; 2008 Aug; 22(7):579-86. PubMed ID: 18756360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUV correction for injection errors in FDG-PET examination.
    Miyashita K; Takahashi N; Oka T; Asakawa S; Lee J; Shizukuishi K; Inoue T
    Ann Nucl Med; 2007 Dec; 21(10):607-13. PubMed ID: 18092139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.
    Halpern BS; Dahlbom M; Auerbach MA; Schiepers C; Fueger BJ; Weber WA; Silverman DH; Ratib O; Czernin J
    J Nucl Med; 2005 Apr; 46(4):603-7. PubMed ID: 15809482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients.
    Ohno Y; Koyama H; Nogami M; Takenaka D; Yoshikawa T; Yoshimura M; Ohbayashi C; Sugimura K
    J Magn Reson Imaging; 2007 Oct; 26(4):1071-80. PubMed ID: 17896365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
    Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
    Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of local statistical noise in PET images induced by attenuation inside the body.
    Kitamura H; Inoue K; Sasaki T; Tsuda K; Fujimori H; Tanaka T; Fukushi M; Moriyama N; Fujii H
    Ann Nucl Med; 2010 Apr; 24(3):197-205. PubMed ID: 20229366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved dose regimen in pediatric PET.
    Accorsi R; Karp JS; Surti S
    J Nucl Med; 2010 Feb; 51(2):293-300. PubMed ID: 20080887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ; Zhang YX; Wei H; Jia Q
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.
    Beyer T; Bockisch A; Kühl H; Martinez MJ
    J Nucl Med; 2006 Jan; 47(1):91-9. PubMed ID: 16391192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different techniques for stereotactic positron emission tomography imaging.
    Novotny J; Nechvil K; Ptacek J; Novotny J; Liscak R
    Stereotact Funct Neurosurg; 2008; 86(1):30-6. PubMed ID: 17881886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A; Kalinyak JE; McDougall IR
    Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient weight-based acquisition protocols to optimize (18)F-FDG PET/CT image quality.
    Nagaki A; Onoguchi M; Matsutomo N
    J Nucl Med Technol; 2011 Jun; 39(2):72-6. PubMed ID: 21565951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat-constrained 18F-FDG PET reconstruction in hybrid PET/MR imaging.
    Prevrhal S; Heinzer S; Wülker C; Renisch S; Ratib O; Börnert P
    J Nucl Med; 2014 Oct; 55(10):1643-9. PubMed ID: 25168626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.